- AU$62.34m
- AU$10.35m
- $33.61m
- 67
- 47
- 57
- 59
C2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 31.4 | 23.1 | 30.1 | 40.6 | 33.6 |
Cost of Revenue | |||||
Gross Profit | 20.3 | 9.64 | 17.4 | 27.9 | 18.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 50.8 | 28 | 21.7 | 17.8 | 41 |
Operating Profit | -19.4 | -4.93 | 8.4 | 22.7 | -7.34 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -18.4 | -1.36 | -4.63 | 19.8 | -9.92 |
Provision for Income Taxes | |||||
Net Income After Taxes | -18.4 | -1.36 | -4.64 | 15.5 | -7.01 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -18.4 | -1.36 | -0.45 | 15.5 | -7.01 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -18.4 | -1.36 | -0.45 | 15.5 | -7.01 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.008 | -0 | -0 | 0.003 | 0.001 |
Special Dividends per Share |